FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116635255> ?p ?o ?g. }

• W2116635255 endingPage "75" @default.
• W2116635255 startingPage "66" @default.
• W2116635255 abstract "Apolipoprotein A-IMilano (ApoA-IM), a naturally occurring Arg 173 to Cys mutant of ApoA-I, has been shown to reduce atherosclerosis in animal models and in a small phase 2 human trial. We have shown superior atheroprotective effects of ApoA-IM gene compared with wild-type ApoA-I gene using transplantation of retrovirally transduced bone marrow in ApoA-I/ApoE null mice. In this study, we compared the antiatherogenic efficacy of ApoA-IM gene transfer using Recombinant adeno-associated virus (rAAV) 2 or rAAV8 as vectors in ApoA-I/ApoE null mice. Mice received a single intravenous injection of 1.2 × 10 12 vector genomes of AAV2 or AAV8 vectors expressing ApoA-IM or control empty vectors (12 mice/group). Circulating levels of ApoA-IM were higher in recipients of AAV8 compared with AAV2 at 4, 12, and 20 weeks postinjection. Qualitative polymerase chain reaction analysis of RNA collected from different tissues showed that the AAV8-mediated gene transfer resulted in a more efficient transgene expression in the heart, brain, liver, lung, spleen, and kidney of the recipient mice compared with AAV2. Intravenous AAV8-ApoA-IM injection reduced atherosclerosis in the whole aorta ( P < .01), aortic sinuses ( P < .05), and brachiocephalic arteries ( P < .05) compared with the vector control, whereas there was no statistically significant reduction in atherosclerosis in mice receiving intravenous AAV2-ApoA-IM. The ApoA-IM gene was expressed in the aortic tissue of mice receiving AAV8 ApoA-IM but not in those receiving AAV2 ApoA-IM. Immunostaining showed that compared with the vector control, there was reduced macrophage content in the brachiocephalic ( P < .05) and aortic sinus plaques ( P < .05) of AAV8 ApoA-IM recipients but not in the recipients of AAV2 ApoA-IM. Thus, intravenous injection of AAV8 is more effective than intravenous injection of AAV2 in the expression of ApoA-IM gene. These data provide support for the potential feasibility of this approach for atheroprotection in humans." @default.
• W2116635255 created "2016-06-24" @default.
• W2116635255 creator A5003094687 @default.
• W2116635255 creator A5042410509 @default.
• W2116635255 creator A5042731770 @default.
• W2116635255 creator A5060622905 @default.
• W2116635255 creator A5073190834 @default.
• W2116635255 creator A5075189232 @default.
• W2116635255 date "2014-04-17" @default.
• W2116635255 modified "2023-09-28" @default.
• W2116635255 title "Comparative Antiatherogenic Effects of Intravenous AAV8- and AAV2-Mediated ApoA-IMilano Gene Transfer in Hypercholesterolemic Mice" @default.
• W2116635255 cites W1516536249 @default.
• W2116635255 cites W1683923016 @default.
• W2116635255 cites W1975528602 @default.
• W2116635255 cites W1987887111 @default.
• W2116635255 cites W1991971673 @default.
• W2116635255 cites W1993601321 @default.
• W2116635255 cites W2007710555 @default.
• W2116635255 cites W2028841673 @default.
• W2116635255 cites W2043872467 @default.
• W2116635255 cites W2044683336 @default.
• W2116635255 cites W2054375155 @default.
• W2116635255 cites W2072026295 @default.
• W2116635255 cites W2072754618 @default.
• W2116635255 cites W2095336654 @default.
• W2116635255 cites W2142065933 @default.
• W2116635255 cites W2154339180 @default.
• W2116635255 cites W2165628592 @default.
• W2116635255 cites W2165894715 @default.
• W2116635255 cites W2327861940 @default.
• W2116635255 cites W2329913019 @default.
• W2116635255 cites W71984142 @default.
• W2116635255 doi "https://doi.org/10.1177/1074248414530041" @default.
• W2116635255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24742767" @default.
• W2116635255 hasPublicationYear "2014" @default.
• W2116635255 type Work @default.
• W2116635255 sameAs 2116635255 @default.
• W2116635255 citedByCount "5" @default.
• W2116635255 countsByYear W21166352552015 @default.
• W2116635255 countsByYear W21166352552017 @default.
• W2116635255 countsByYear W21166352552018 @default.
• W2116635255 countsByYear W21166352552019 @default.
• W2116635255 crossrefType "journal-article" @default.
• W2116635255 hasAuthorship W2116635255A5003094687 @default.
• W2116635255 hasAuthorship W2116635255A5042410509 @default.
• W2116635255 hasAuthorship W2116635255A5042731770 @default.
• W2116635255 hasAuthorship W2116635255A5060622905 @default.
• W2116635255 hasAuthorship W2116635255A5073190834 @default.
• W2116635255 hasAuthorship W2116635255A5075189232 @default.
• W2116635255 hasConcept C102230213 @default.
• W2116635255 hasConcept C104317684 @default.
• W2116635255 hasConcept C111599444 @default.
• W2116635255 hasConcept C126322002 @default.
• W2116635255 hasConcept C153911025 @default.
• W2116635255 hasConcept C203014093 @default.
• W2116635255 hasConcept C2778163477 @default.
• W2116635255 hasConcept C2779134260 @default.
• W2116635255 hasConcept C2780091579 @default.
• W2116635255 hasConcept C2780931953 @default.
• W2116635255 hasConcept C2911091166 @default.
• W2116635255 hasConcept C55493867 @default.
• W2116635255 hasConcept C57089818 @default.
• W2116635255 hasConcept C62746215 @default.
• W2116635255 hasConcept C71924100 @default.
• W2116635255 hasConcept C86803240 @default.
• W2116635255 hasConceptScore W2116635255C102230213 @default.
• W2116635255 hasConceptScore W2116635255C104317684 @default.
• W2116635255 hasConceptScore W2116635255C111599444 @default.
• W2116635255 hasConceptScore W2116635255C126322002 @default.
• W2116635255 hasConceptScore W2116635255C153911025 @default.
• W2116635255 hasConceptScore W2116635255C203014093 @default.
• W2116635255 hasConceptScore W2116635255C2778163477 @default.
• W2116635255 hasConceptScore W2116635255C2779134260 @default.
• W2116635255 hasConceptScore W2116635255C2780091579 @default.
• W2116635255 hasConceptScore W2116635255C2780931953 @default.
• W2116635255 hasConceptScore W2116635255C2911091166 @default.
• W2116635255 hasConceptScore W2116635255C55493867 @default.
• W2116635255 hasConceptScore W2116635255C57089818 @default.
• W2116635255 hasConceptScore W2116635255C62746215 @default.
• W2116635255 hasConceptScore W2116635255C71924100 @default.
• W2116635255 hasConceptScore W2116635255C86803240 @default.
• W2116635255 hasIssue "1" @default.
• W2116635255 hasLocation W21166352551 @default.
• W2116635255 hasLocation W21166352552 @default.
• W2116635255 hasOpenAccess W2116635255 @default.
• W2116635255 hasPrimaryLocation W21166352551 @default.
• W2116635255 hasRelatedWork W1583480181 @default.
• W2116635255 hasRelatedWork W1999237392 @default.
• W2116635255 hasRelatedWork W2060345071 @default.
• W2116635255 hasRelatedWork W2069147439 @default.
• W2116635255 hasRelatedWork W2125387769 @default.
• W2116635255 hasRelatedWork W2126239395 @default.
• W2116635255 hasRelatedWork W2138955227 @default.
• W2116635255 hasRelatedWork W2371601817 @default.
• W2116635255 hasRelatedWork W2460875162 @default.
• W2116635255 hasRelatedWork W2738867127 @default.
• W2116635255 hasVolume "20" @default.
• W2116635255 isParatext "false" @default.

• next